Strong interferon-inducing capacity of a highly virulent variant of influenza A virus strain PR8 with deletions in the NS1 gene

References

1. Bergmann M., Garcia-Sastre A., Carnero E., Pehamberger H., Wolff K., Palese P., Muster T. 2000; Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J Virol 74:6203–6206 [CrossRef]
   [Google Scholar]
2. Burgui I., Aragon T., Ortin J., Nieto A. 2003; PABP1 and eIF4GI associate with influenza virus NS1 protein in viral mRNA translation initiation complexes. J Gen Virol 84:3263–3274 [CrossRef]
   [Google Scholar]
3. Das K., Ma L. C., Xiao R., Radvansky B., Aramini J., Zhao L., Marklund J., Kuo R. L., Twu K. Y. other authors 2008; Structural basis for suppression of a host antiviral response by influenza A virus. Proc Natl Acad Sci U S A 105:13093–13098 [CrossRef]
   [Google Scholar]
4. Donelan N. R., Basler C. F., Garcia-Sastre A. 2003; A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice. J Virol 77:13257–13266 [CrossRef]
   [Google Scholar]
5. Egorov A., Brandt S., Sereinig S., Romanova J., Ferko B., Katinger D., Grassauer A., Alexandrova G., Katinger H., Muster T. 1998; Transfectant influenza A viruses with long deletions in the NS1 protein grow efficiently in Vero cells. J Virol 72:6437–6441
   [Google Scholar]
6. Ehrhardt C., Wolff T., Pleschka S., Planz O., Beermann W., Bode J. G., Schmolke M., Ludwig S. 2007; Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses. J Virol 81:3058–3067 [CrossRef]
   [Google Scholar]
7. Enami K., Sato T. A., Nakada S., Enami M. 1994; Influenza virus NS1 protein stimulates translation of the M1 protein. J Virol 68:1432–1437
   [Google Scholar]
8. Falcon A. M., Marion R. M., Zurcher T., Gomez P., Portela A., Nieto A., Ortin J. 2004; Defective RNA replication and late gene expression in temperature-sensitive influenza viruses expressing deleted forms of the NS1 protein. J Virol 78:3880–3888 [CrossRef]
   [Google Scholar]
9. Garcia-Sastre A. 2001; Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses. Virology 279:375–384 [CrossRef]
   [Google Scholar]
10. Garcia-Sastre A., Egorov A., Matassov D., Brandt S., Levy D. E., Durbin J. E., Palese P., Muster T. 1998; Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252:324–330 [CrossRef]
    [Google Scholar]
11. Grimm D., Staeheli P., Hufbauer M., Koerner I., Martinez-Sobrido L., Solorzano A., Garcia-Sastre A., Haller O., Kochs G. 2007; Replication fitness determines high virulence of influenza A virus in mice carrying functional Mx1 resistance gene. Proc Natl Acad Sci U S A 104:6806–6811 [CrossRef]
    [Google Scholar]
12. Hale B. G., Jackson D., Chen Y. H., Lamb R. A., Randall R. E. 2006; Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling. Proc Natl Acad Sci U S A 103:14194–14199 [CrossRef]
    [Google Scholar]
13. Hale B. G., Randall R. E., Ortin J., Jackson D. 2008; The multifunctional NS1 protein of influenza A viruses. J Gen Virol 89:2359–2376 [CrossRef]
    [Google Scholar]
14. Haller O., Kochs G., Weber F. 2006; The interferon response circuit: induction and suppression by pathogenic viruses. Virology 344:119–130 [CrossRef]
    [Google Scholar]
15. Haller O., Stertz S., Kochs G. 2007; The Mx GTPase family of interferon-induced antiviral proteins. Microbes Infect 9:1636–1643 [CrossRef]
    [Google Scholar]
16. Hayman A., Comely S., Lackenby A., Murphy S., McCauley J., Goodbourn S., Barclay W. 2006; Variation in the ability of human influenza A viruses to induce and inhibit the IFN- β pathway. Virology 347:52–64 [CrossRef]
    [Google Scholar]
17. Iwamura T., Yoneyama M., Yamaguchi K., Suhara W., Mori W., Shiota K., Okabe Y., Namiki H., Fujita T. 2001; Induction of IRF-3/-7 kinase and NF- κ B in response to double-stranded RNA and virus infection: common and unique pathways. Genes Cells 6:375–388 [CrossRef]
    [Google Scholar]
18. Jorns C., Holzinger D., Thimme R., Spangenberg H. C., Weidmann M., Rasenack J., Blum H. E., Haller O., Kochs G. 2006; Rapid and simple detection of IFN-neutralizing antibodies in chronic hepatitis C non-responsive to IFN- α . J Med Virol 78:74–82 [CrossRef]
    [Google Scholar]
19. Kochs G., Garcia-Sastre A., Martinez-Sobrido L. 2007a; Multiple anti-interferon actions of the influenza A virus NS1 protein. J Virol 81:7011–7021 [CrossRef]
    [Google Scholar]
20. Kochs G., Koerner I., Thiel L., Kothlow S., Kaspers B., Ruggli N., Summerfield A., Pavlovic J., Stech J., Staeheli P. 2007b; Properties of H7N7 influenza A virus strain SC35M lacking interferon antagonist NS1 in mice and chickens. J Gen Virol 88:1403–1409 [CrossRef]
    [Google Scholar]
21. Krug R. M., Yuan W., Noah D. L., Latham A. G. 2003; Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein. Virology 309:181–189 [CrossRef]
    [Google Scholar]
22. Kuo R. L., Krug R. M. 2009; Influenza a virus polymerase is an integral component of the CPSF30–NS1A protein complex in infected cells. J Virol 83:1611–1616 [CrossRef]
    [Google Scholar]
23. Li S., Min J. Y., Krug R. M., Sen G. C. 2006; Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology 349:13–21 [CrossRef]
    [Google Scholar]
24. Lienenklaus S., Cornitescu M., Zietara N., Lyszkiewicz M., Gerkara N., Jablonska J., Edenhofer F., Rajewsky K., Bruder D. other authors 2009; Novel reporter mouse reveals constitutive and inflammatory expression of IFN- β in vivo. J Immunol 183:3229–3236 [CrossRef]
    [Google Scholar]
25. Marion R. M., Zurcher T., de la Luna S., Ortin J. 1997; Influenza virus NS1 protein interacts with viral transcription-replication complexes in vivo . J Gen Virol 78:2447–2451
    [Google Scholar]
26. Mibayashi M., Martinez-Sobrido L., Loo Y. M., Cardenas W. B., Gale M., Jr & Garcia-Sastre A. 2007; Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol 81:514–524 [CrossRef]
    [Google Scholar]
27. Min J. Y., Krug R. M. 2006; The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: inhibiting the 2′–5′ oligo (A) synthetase/RNase L pathway. Proc Natl Acad Sci U S A 103:7100–7105 [CrossRef]
    [Google Scholar]
28. Mordstein M., Kochs G., Dumoutier L., Renauld J. C., Paludan S. R., Klucher K., Staeheli P. 2008; Interferon- λ contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog 4:e1000151 [CrossRef]
    [Google Scholar]
29. Noah D. L., Twu K. Y., Krug R. M. 2003; Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3′ end processing of cellular pre-mRNAS. Virology 307:386–395 [CrossRef]
    [Google Scholar]
30. Pichlmair A., Schulz O., Tan C. P., Naslund T. I., Liljestrom P., Weber F., Reis. e Sousa C. 2006; RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314:997–1001 [CrossRef]
    [Google Scholar]
31. Quinlivan M., Zamarin D., Garcia-Sastre A., Cullinane A., Chambers T., Palese P. 2005; Attenuation of equine influenza viruses through truncations of the NS1 protein. J Virol 79:8431–8439 [CrossRef]
    [Google Scholar]
32. Reed L. J., Muench H. 1938; A simple method of estimating fifty percent endpoints. Am J Hyg 27:493–497
    [Google Scholar]
33. Rolling T., Koerner I., Zimmermann P., Holz K., Haller O., Staeheli P., Kochs G. 2009; Adaptive mutations resulting in enhanced polymerase activity contribute to high virulence of influenza A virus in mice. J Virol 83:6673–6680 [CrossRef]
    [Google Scholar]
34. Satterly N., Tsai P. L., van Deursen J., Nussenzveig D. R., Wang Y., Faria P. A., Levay A., Levy D. E., Fontoura B. M. 2007; Influenza virus targets the mRNA export machinery and the nuclear pore complex. Proc Natl Acad Sci U S A 104:1853–1858 [CrossRef]
    [Google Scholar]
35. Seo S. H., Hoffmann E., Webster R. G. 2002; Lethal H5N1 influenza viruses escape host anti-viral cytokine response. Nat Med 8:950–954 [CrossRef]
    [Google Scholar]
36. Shin Y. K., Liu Q., Tikoo S. K., Babiuk L. A., Zhou Y. 2007; Influenza A virus NS1 protein activates the phosphatidylinositol 3-kinase (PI3K)/Akt pathway by direct interaction with the p85 subunit of PI3K. J Gen Virol 88:13–18 [CrossRef]
    [Google Scholar]
37. Solorzano A., Webby R. J., Lager K. M., Janke B. H., Garcia-Sastre A., Richt J. A. 2005; Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs. J Virol 79:7535–7543 [CrossRef]
    [Google Scholar]
38. Staeheli P., Haller O., Boll W., Lindenmann J., Weissmann C. 1986; Mx protein: constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus. Cell 44:147–158 [CrossRef]
    [Google Scholar]
39. Talon J., Horvath C. M., Polley R., Basler C. F., Muster T., Palese P., Garcia-Sastre A. 2000; Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol 74:7989–7996 [CrossRef]
    [Google Scholar]
40. Wang X., Basler C. F., Williams B. R., Silverman R. H., Palese P., Garcia-Sastre A. 2002; Functional replacement of the carboxy-terminal two-thirds of the influenza A virus NS1 protein with short heterologous dimerization domains. J Virol 76:12951–12962 [CrossRef]
    [Google Scholar]